Immuneering Overview
- Founded
- 2008

- Status
- Acquired/Merged
- Employees
- 60

- Latest Deal Type
- Series B
- Latest Deal Amount
- $62M

- Investors
- 8
Immuneering General Information
Description
Developer of a disease canceling technology designed to forge a new approach to drug discovery, develop transformative medicines, and help others make the most of their data. The company's technology is focused on treating aspects of the disease that have eluded conventional approaches, including cancer cachexia and metastasis, enabling clients in the healthcare sectors to manufacture drugs to counteract several critical diseases.
Contact Information
(Operating Subsidiary)
- 245 Main Street
- 2nd Floor
- Cambridge, MA 02142
- United States
Immuneering Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC (Series B) | 05-Jan-2021 | $62M | 0000 | Completed | Pre-Clinical Trials | |
2. Later Stage VC (Series A) | 16-Dec-2019 | 0000 | 0000 | 0000 | Completed | Pre-Clinical Trials |
1. Merger/Acquisition | 30-Sep-2015 | $60M | 00000 | Completed | Pre-Clinical Trials |
Immuneering Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Immuneering Comparisons
Industry
000000 0
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialImmuneering Competitors (11)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Second Genome | Venture Capital-Backed | Brisbane, CA | 00 | 000.00 | 00000000000 | 000.00 |
00000000 | Venture Capital-Backed | Houston, TX | 00 | 00.000 | 0000000000 0 | 00.000 |
0000000000 | Formerly VC-backed | Menlo Park, CA | 000 | 00000 | 00000000 | 00000 |
000000000 | Venture Capital-Backed | Ann Arbor, MI | 00 | 000.00 | 0000000000 0 | 000.00 |
00000000 | Formerly VC-backed | San Diego, CA | 0000 | 00000 | 000000&0 |
Immuneering Executive Team (6)
Immuneering Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Bob Carpenter | Immuneering | Co-Founder & Board Member | 000 0000 |
Joseph Kekst | Self | Board Member | 000 0000 |
Peter Feinberg | Self | Board Observer | 000 0000 |
Immuneering Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial